Imaging in Clinical Trials - a Questionnaire Study to Assess Impact of Imaging Regimes on Patient Participation

Imaging in Clinical Trials - a Questionnaire Study to Assess Impact of Imaging Regimes on Patient Participation

Sponsors

Lead sponsor: Institute of Cancer Research, United Kingdom

Collaborator: National Institute for Health Research, United Kingdom
Royal Marsden NHS Foundation Trust

Source Institute of Cancer Research, United Kingdom
Brief Summary

This research is aimed at finding out what may influence the decision of patients to participate in trials involving imaging so that the investigators may improve our future studies so they are more patient focused and acceptable in regards to scan schedules.

Detailed Description

This is a questionnaire study aimed at gaining a greater understanding of the patient perspective on undertaking imaging procedures, MRI and PET/CT, for research purposes. The study is to evaluate the patient opinion and perceptions of the burden of imaging associated with research. We will look at different scanning procedures of varying duration, intensity, frequency and scheduling; this will enable us to have a better understand of the factors that influence participation in research and thus help us develop protocols that are more patient focused and acceptable.

Overall Status Completed
Start Date April 1, 2015
Completion Date August 1, 2018
Primary Completion Date August 1, 2018
Study Type Observational
Primary Outcome
Measure Time Frame
Factors that affect patient participation in imaging research Duration of Study - 1 year
Secondary Outcome
Measure Time Frame
Factors affecting participation in the different patient categories Duration of Study - 1 year
Effect of current participation in a study on the perceived acceptability of imaging burden Duration of Study - 1 year
Do opinions change after undergoing imaging procedures Duration of Study - 1 year
Enrollment 207
Condition
Intervention

Intervention type: Other

Intervention name: Questionnaire

Description: A short questionnaire (9 questions) will be given to the participants to complete.

Eligibility

Sampling method: Probability Sample

Criteria:

Inclusion Criteria

- Being treated at The Royal Marsden Hospital

- Over the age of 18

- Having imaging (MRI or PET/CT) as part of research or clinical care.

- Group 1

- Currently enrolled in a research project that involves imaging (either MRI or PET/CT)

- Group 2

- Previously enrolled in a research project that involved imaging (either MRI or PET/CT), where the patients involvement in the research project has now ended.

- Group 3

- Patients attending the MRI or PET/CT departments for imaging as part of their standard clinical care.

Exclusion Criteria -

- Inability to complete the questionnaire.

- Previously completed questionnaire.

Gender: All

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Location
facility
The Royal Marsden NHS Foundation Trust
Location Countries

United Kingdom

Verification Date

January 2020

Responsible Party

Responsible party type: Principal Investigator

Investigator affiliation: Institute of Cancer Research, United Kingdom

Investigator full name: Nandita deSouza

Investigator title: Professor of Translational Imaging

Keywords
Has Expanded Access No
Arm Group

Arm group label: Group 1

Description: Patients currently recruited to studies with imaging at The Marsden

Arm group label: Group 2

Description: Patients who have previously participated in studies with imaging at The Marsden

Arm group label: Group 3

Description: Patients attending for scans as part of their clinical pathway

Acronym ASK
Study Design Info

Observational model: Cohort

Time perspective: Prospective

Source: ClinicalTrials.gov